November 14-15, 2017
“Now in its eighth year, the Jefferies Conference is the largest healthcare-dedicated conference in Europe. This year, we hosted 350 participating companies, 1,400 attendees and 3,400 investor and business-to-business meetings. The event featured leading public and private companies from the pharmaceuticals, biotechnology, generics, consumer health, animal health, medical technology and healthcare services sectors from the United States, Europe, Africa, Middle East, Latin America, Russia, India, Israel,
October 25-26, 2017
New York, USA
“Presented by the Galien Foundation and Business France, the Prix Galien – MedStartUp Award encourages and rewards the most promising startups in Healthcare formed through international partnerships between French, Israeli, and North American innovators. The program brings together companies from the pharmaceutical, biotechnology, medical technology and healthcare industries, where innovation, scientific excellence and commercial goals are paramount” (galienfoundation.org)
ENYO Pharma is proud to announce its participation to the 4th Galien Medstartup 2017 program in New York on October 25-26th.
October 20-24, 2017
Washington DC, USA
AASLD will see you in Boston, MA, where more than 9,500 hepatologists and hepatology health professionals from across the nation and around the world will gather at The Liver Meeting® to exchange the latest liver diseases research, discuss treatment outcomes, and interact with colleagues at the annual must-attend even in the science and practice of hepatology.
June 19-22, 2017
San Diego, CA, USA
The BIO International Convention is a global event which attracts over 15,000 biotechnology and pharma leaders, academic institutions, research centres and associated organizations from the 50 states of America and 33 other countries who come together for one week of intensive networking to discover new opportunities and promising partnerships.
22-23 May, 2017
Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial community and business development and licensing professionals to do business with independently selected Presenting Companies.
Now celebrating its 18th meeting, Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects.